PI3Ka is a principal Ras effector that phosphorylates PIP 2 to PIP 3 in the PI3K/Akt/mTOR pathway. How Ras activates PI3K has been unclear: is Ras' role confined to PI3K recruitment to the membrane or does Ras activation also involve allostery? Recently, we determined the mechanism of PI3Ka activation at the atomic level. We showed the vital role and significance of conformational change in PI3Ka activation.Here, by a 'best-match for hydrogen-bonding pair' (BMHP) computational protocol and molecular dynamics (MD) simulations, we model the atomic structure of KRas4B in complex with the Ras binding domain (RBD) of PI3Ka, striving to understand the mechanism of PI3Ka activation by Ras. Point mutations T208D, K210E, and K227E disrupt the KRas4B-RBD interface in the models, in line with the experiments. We identify allosteric signaling pathways connecting Ras to RBD in the p110a subunit.However, the observed weak allosteric signals coupled with the detailed mechanism of PI3Ka activation make us conclude that the dominant mechanistic role of Ras is likely to be recruitment and restriction of the PI3Ka population at the membrane. Thus, RTK recruits the PI3Ka to the membrane and activates it by relieving its autoinhibition exerted by the nSH2 domain, leading to exposure of the kinase domain, which permits PIP 2 binding. Ras recruitment can shift the PI3Ka ensemble toward a population where the kinase domain surface and the active site position and orientation favor PIP 2 insertion. This work helps elucidate Ras-mediated PI3K activation and explores the structural basis for Ras-PI3Ka drug discovery.